Published in Medical Letter on the CDC and FDA, July 12th, 2009
"This is a positive development by PharmaSwiss," said Stephen M. Simes, president & CEO of BioSante. "We believe PharmaSwiss is in an excellent position to capture an important share of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.